Who should get it? Wen: The US Centers for Disease Control and Prevention recommends two doses of the recombinant zoster vaccine, called Shingrix, for adults 50 and older . This age recommendation ...

The Recombinant Zoster vaccine (RZV, commercially known as SHINGRIX TM) offers strong protection against shingles, but there’s still a lot we don’t understand about how the immune system prevents ...

Vaccination with GSK's recombinant shingles vaccine, Shingrix, could delay the onset of dementia, according to researchers in the UK. A study published in Nature Medicine suggests that people ...

Questions and answers are republished by permission. Q: I had the two doses of the Shingrix vaccine in 2018 for shingles. I’m 77 years old. Does its effectiveness wane? Should I have another ...

An important next step is testing whether today’s vaccine, Shingrix, also offers dementia protection, Nagel said. Another research group recently reported some evidence that it does. Vaccine ...

Previous research suggested that "shingles vaccinations might reduce dementia risk," including a 2024 study that found even greater protection from the newer vaccine Shingrix, The New York Times said.

(Zostavax was eventually replaced with another shingles vaccine called Shingrix in the U.K., the U.S. and many other countries. The authors of the new study noted that they focused on Zostavax ...